Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The dark side of cannabis: increased risk of psychosis

Ken Finn, MD
Conditions
January 31, 2023
60 Shares
Share
Tweet
Share

Psychosis is a broad term that describes a change in the perception of reality. It can be caused by various conditions, including metabolic, psychiatric, neurologic, genetic, and other medical conditions, as well as licit and illicit substances, particularly cannabis. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) states that abnormalities define these disorders in one or more of the following five domains: delusions, hallucinations, disorganized thinking (speech), grossly disorganized or abnormal motor behavior (including catatonia), and negative symptoms.

Cannabis-induced psychosis has been subject to debate but is becoming more prevalent in areas where use rates are increasing. This increase may be related to improved diagnostic evaluation, medical coding, increased understanding of the condition, and increased cannabis potency. Studies have shown a 3-fold increased risk of psychosis with “skunk,” which is generally accepted as cannabis with more than 10 percent tetrahydrocannabinol (THC) content.

Violence associated with psychosis has also been well-documented. Marijuana use may be associated with increased impulsivity on the same day and the following day relative to days when marijuana was not used. It is also associated with increased hostile behaviors and perceptions of hostility in others on the same day compared to days when marijuana was not used. Cannabis use disorder appears to increase the risk of aggression towards others, particularly among youths. There is also evidence of a moderate association between cannabis use and physical violence.

Psychosis can be caused by various conditions, including licit and illicit substances, particularly cannabis. Cannabis has a higher conversion rate to psychosis than other substances. 32 percent of patients with substance-induced psychosis convert to either bipolar or schizophrenia-spectrum disorders, with the highest conversion rate found with cannabis-induced psychosis (47 percent). There is debate about the causal relationship between cannabis and psychosis. However, this can be demonstrated using Bradford-Hill criteria. Despite this, psychosis is often multifactorial in many instances. Cannabis exposure increases the risk of psychosis, from transient psychotic states to chronic recurrent psychosis. In individuals with established psychosis, cannabis has a negative impact on the course and expression of the illness.

Individuals who use cannabis frequently are at an increased risk of psychosis, with no significant risk associated with less frequent use. There is a significant dose-response association between cannabis use frequency and psychosis development. Frequently overlooked is the fact that psychosis precipitated by cannabis use may persist, despite cessation, and may not resolve. Recent data shows that hospitalizations for psychosis/cannabis use are more likely in areas where cannabis is legalized, and recreational cannabis legalization is associated with a greater rate of hospitalization for psychosis associated with cannabis use.

Several likely factors contribute to the trend of cannabis-induced psychosis, including increased normalization of cannabis use, decreased perception of harm, rapid development of higher potency products in recent years, and products with less cannabidiol, which has been shown to have a potential protective effect. Furthermore, progression to schizophrenia is highest in those with cannabis-induced psychotic disorder and is predicted by early age at diagnosis of substance-induced psychotic disorder, male sex, and other episodes of drug abuse, alcohol use disorder, and substance-induced psychotic disorder.

Adolescents who use cannabis report more psychotic-like symptoms than controls and more than adults, independent of depression and anxiety. Delaying onset of use, discouraging the use of products with greater than 10 percent THC content and preventing daily or near-daily use should be part of the educational process, starting at early ages. Potency caps should be mandated as “high potency” cannabis should be considered in any product with greater than 10 percent THC due to a 5-fold risk of developing psychosis, according to more recent data.

It would be critical that areas expanding cannabis programs seriously consider mandatory drug testing on any violent crime, including mass shootings, which are becoming more prevalent, and make those findings public. Public health campaigns, underscoring the health risks of cannabis, including psychosis, should be strongly encouraged and disseminated to the medical community, general public, and state legislators to allow for better-informed policy development. Consistency in testing is strongly recommended. The potential relationship between cannabis use and psychosis cannot be ignored.

Ken Finn is a physiatrist.

Prev

Be a prepared physician: laceration repair kits for your home, vacation home, and cars

January 31, 2023 Kevin 0
…
Next

The dark side of celebrity medicine

January 31, 2023 Kevin 0
…

Tagged as: Medications

Post navigation

< Previous Post
Be a prepared physician: laceration repair kits for your home, vacation home, and cars
Next Post >
The dark side of celebrity medicine

Related Posts

  • The risk physicians take when going on social media

    Anonymous
  • The can and can’t of cannabis

    Eunice Zhang, MD
  • Cannabis stigma continues to impede patient care

    Jill Becker, MD
  • Clearing the misinformation surrounding medical cannabis

    Samoon Ahmad, MD and Kevin Hill, MD
  • 5 urban legends about risk-adjusted diagnosis coding

    Betsy Nicoletti, MS
  • Federal legalization of cannabis: What does it mean for patients?

    Jill Becker, MD

More in Conditions

  • Overcoming Parkinson’s: a journey of laughter and resilience

    Cynthia Poire Mathews, FNP
  • The untold struggles patients face with resident doctors

    Denise Reich
  • Maximize sleep efficiency with stimulus control

    Pedram Navab, DO
  • The endless waves of chronic illness

    Michele Luckenbaugh
  • Surviving and thriving after life’s most difficult moments

    Rebecca Fogg, MBA
  • The surprising power of Play-Doh in pediatric care: How it’s bringing families together

    Alexander Rakowsky, MD
  • Most Popular

  • Past Week

    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Tom Brady’s legacy and the importance of personal integrity in end-of-life choices

      Kevin Haselhorst, MD | Physician
    • The hidden truths of hospital life: What doctors wish you knew

      Emily Stanford, DO | Physician
    • 10 commandments of ethical affiliate marketing for physicians

      Aaron Morgenstein, MD & Amy Bissada, DO | Finance
    • The heart of a Desi doctor: Balancing emotions and resources in oncology

      Dr. Damane Zehra | Physician
    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Journal Shows Its Commitment to Exploring AI in Medicine
  • Do Away With 'Lockout' Period in iPLEDGE, FDA Advisors Urge
  • Cluster Headache, Migraine Linked to Circadian System
  • Smaller Liver Transplant Candidates Wait Longer, Less Likely to Receive Organ
  • A 'Double Whammy' for Gastric Cancer Risk

Meeting Coverage

  • Oral Roflumilast Effective in the Treatment of Plaque Psoriasis
  • Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer
  • Cannabis Use Common in Post-Surgery Patients on Opioid Tapering
  • Less Abuse With Extended-Release Oxycodone, Poison Center Data Suggest
  • Novel Strategies Show Winning Potential in Ovarian Cancer
  • Most Popular

  • Past Week

    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Tom Brady’s legacy and the importance of personal integrity in end-of-life choices

      Kevin Haselhorst, MD | Physician
    • The hidden truths of hospital life: What doctors wish you knew

      Emily Stanford, DO | Physician
    • 10 commandments of ethical affiliate marketing for physicians

      Aaron Morgenstein, MD & Amy Bissada, DO | Finance
    • The heart of a Desi doctor: Balancing emotions and resources in oncology

      Dr. Damane Zehra | Physician
    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The dark side of cannabis: increased risk of psychosis
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...